Company Description
TAP REAL ESTATE TECHNOLOGIES (OTC Link: RWAX) is a publicly traded real estate services company in the Real Estate sector. The company has a market capitalization of $12.1M.
RWAX stock has gained 50.0% over the past year. Shares last traded at $0.0003.
On a trailing twelve-month basis, TAP REAL ESTATE TECHNOLOGIES reported revenue of $0 and diluted earnings per share of $0.00.
This page provides a comprehensive overview of RWAX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TAP REAL ESTATE TECHNOLOGIES (RWAX) stock last traded at $0.0003. Over the past 12 months, the stock has gained 50.0%. At a market capitalization of $12.1M, RWAX is classified as a micro-cap stock with approximately 60.7B shares outstanding.
RWAX Rankings
Latest News
TAP REAL ESTATE TECHNOLOGIES has 4 recent news articles, with the latest published 2 days ago. Key topics include AI. View all RWAX news →
SEC Filings
TAP REAL ESTATE TECHNOLOGIES has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on July 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RWAX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in TAP REAL ESTATE TECHNOLOGIES (RWAX) currently stands at 9.2 million shares, down 10.4% from the previous reporting period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has increased by 231.6%.
Days to Cover History
Days to cover for TAP REAL ESTATE TECHNOLOGIES (RWAX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
RWAX Company Profile & Sector Positioning
TAP REAL ESTATE TECHNOLOGIES (RWAX) operates in the Real Estate Services industry within the broader Real Estate sector and is listed on the OTC Link.